MORF4L1P5

Across TCGA pan-cancer cohorts, MORF4L1P5 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MORF4L1P5 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MORF4L1P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MORF4L1P5 expression acts as an unfavorable survival marker, although some lineages such as LAML and LUAD show a favorable association.

DLBC, LUSC, and UVM are the cancer types where MORF4L1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.249	0.965	<.001	141	view →
LUSC	OS	Tertile	II,III,IV	0.390	0.816	<.001	57	view →
UVM	OS	Tertile	III,IV	0.215	0.831	<.001	45	view →
CESC	OS	Tertile	IV	0.121	0.591	.029	36	view →
THCA	OS	Tertile	III,IV	0.586	0.936	<.001	24	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
CHOL	OS	Tertile	II,III,IV	0.080	0.740	.026	18	view →
ACC	OS	Tertile	All	0.213	0.707	.018	15	view →
BLCA	OS	Tertile	IV	0.418	0.622	.038	9	view →
LAML	DFS	Tertile	All	0.643	0.440	.020	8	view →
COAD	DFS	Tertile	All	0.527	0.711	.022	6	view →
LUAD	DFS	Tertile	All	0.674	0.325	.029	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MORF4L1P5–DLBC (OS)

Open the DLBC breakdown →